Literature DB >> 33668781

Alterations of Extracellular Matrix Components in the Course of Juvenile Idiopathic Arthritis.

Magdalena Wojdas1, Klaudia Dąbkowska1, Katarzyna Winsz-Szczotka1.   

Abstract

Juvenile idiopathic arthritis (JIA) is the most common group of chronic connective tissue diseases in children that is accompanied by joint structure and function disorders. Inflammation underlying the pathogenic changes in JIA, caused by hypersecretion of proinflammatory cytokines, leads to the destruction of articular cartilage. The degradation which progresses with the duration of JIA is not compensated by the extent of repair processes. These disorders are attributed in particular to changes in homeostasis of extracellular matrix (ECM) components, including proteoglycans, that forms articular cartilage. Changes in metabolism of matrix components, associated with the disturbance of their degradation and biosynthesis processes, are the basis of the progressive wear of joint structures observed in the course of JIA. Clinical evaluation and radiographic imaging are current methods to identify the destruction. The aim of this paper is to review enzymatic and non-enzymatic factors involved in catabolism of matrix components and molecules stimulating their biosynthesis. Therefore, we discuss the changes in these factors in body fluids of children with JIA and their potential diagnostic use in the assessment of disease activity. Understanding the changes in ECM components in the course of the child-hood arthritis may provide the introduction of both new diagnostic tools and new therapeutic strategies in children with JIA.

Entities:  

Keywords:  extracellular matrix; juvenile idiopathic arthritis; matrix metalloproteinases; proteoglycans; reactive oxygen species

Year:  2021        PMID: 33668781      PMCID: PMC7996267          DOI: 10.3390/metabo11030132

Source DB:  PubMed          Journal:  Metabolites        ISSN: 2218-1989


  120 in total

Review 1.  Series "matrix metalloproteinases in lung health and disease": Biological role of matrix metalloproteinases: a critical balance.

Authors:  S Löffek; O Schilling; C-W Franzke
Journal:  Eur Respir J       Date:  2010-12-22       Impact factor: 16.671

Review 2.  Extracellular matrix remodeling: the common denominator in connective tissue diseases. Possibilities for evaluation and current understanding of the matrix as more than a passive architecture, but a key player in tissue failure.

Authors:  Morten A Karsdal; Mette J Nielsen; Jannie M Sand; Kim Henriksen; Federica Genovese; Anne-Christine Bay-Jensen; Victoria Smith; Joanne I Adamkewicz; Claus Christiansen; Diana J Leeming
Journal:  Assay Drug Dev Technol       Date:  2012-10-09       Impact factor: 1.738

3.  Plasma and urinary glycosaminoglycans in the course of juvenile idiopathic arthritis.

Authors:  Katarzyna Winsz-Szczotka; Kornelia Kuźnik-Trocha; Katarzyna Komosińska-Vassev; Grzegorz Wisowski; Anna Gruenpeter; Iwona Lachór-Motyka; Bogusław Żegleń; Wojciech Lemski; Krystyna Olczyk
Journal:  Biochem Biophys Res Commun       Date:  2015-02-13       Impact factor: 3.575

4.  Aggrecan degradation in human articular cartilage explants is mediated by both ADAMTS-4 and ADAMTS-5.

Authors:  Ruo-Hua Song; Micky D Tortorella; Anne-Marie Malfait; James T Alston; Zhiyong Yang; Elizabeth C Arner; David W Griggs
Journal:  Arthritis Rheum       Date:  2007-02

Review 5.  Nitric oxide synthases: regulation and function.

Authors:  Ulrich Förstermann; William C Sessa
Journal:  Eur Heart J       Date:  2011-09-01       Impact factor: 29.983

6.  Platelet-derived growth factor and transforming growth factor beta synergistically potentiate inflammatory mediator synthesis by fibroblast-like synoviocytes.

Authors:  Sanna Rosengren; Maripat Corr; David L Boyle
Journal:  Arthritis Res Ther       Date:  2010-04-09       Impact factor: 5.156

7.  Reactive oxygen and nitrogen species in patients with rheumatoid arthritis as potential biomarkers for disease activity and the role of antioxidants.

Authors:  Hani M Khojah; Sameh Ahmed; Mahran S Abdel-Rahman; Al-Badr Hamza
Journal:  Free Radic Biol Med       Date:  2016-06-21       Impact factor: 7.376

Review 8.  Impact of cytokines and T lymphocytes upon osteoclast differentiation and function.

Authors:  Matthew T Gillespie
Journal:  Arthritis Res Ther       Date:  2007       Impact factor: 5.156

Review 9.  Matrix metalloproteinases in arthritic disease.

Authors:  Gillian Murphy; Vera Knäuper; Susan Atkinson; George Butler; William English; Mike Hutton; Jan Stracke; Ian Clark
Journal:  Arthritis Res       Date:  2002-05-09

Review 10.  The ADAM metalloproteinases.

Authors:  Dylan R Edwards; Madeleine M Handsley; Caroline J Pennington
Journal:  Mol Aspects Med       Date:  2008-08-15
View more
  6 in total

Review 1.  Juvenile idiopathic arthritis: from aetiopathogenesis to therapeutic approaches.

Authors:  Lina N Zaripova; Angela Midgley; Stephen E Christmas; Michael W Beresford; Eileen M Baildam; Rachel A Oldershaw
Journal:  Pediatr Rheumatol Online J       Date:  2021-08-23       Impact factor: 3.413

2.  Serum lubricin levels in patients with juvenile idiopathic arthritis.

Authors:  Rabia Miray Kisla Ekinci; Sibel Balci; Fatma Coban; Atil Bisgin
Journal:  Reumatologia       Date:  2021-12-09

3.  The Effects of TNF-α Inhibition on the Metabolism of Cartilage: Relationship between KS, HA, HAPLN1 and ADAMTS4, ADAMTS5, TOS and TGF-β1 Plasma Concentrations in Patients with Juvenile Idiopathic Arthritis.

Authors:  Kornelia Kuźnik-Trocha; Katarzyna Winsz-Szczotka; Iwona Lachór-Motyka; Klaudia Dąbkowska; Magdalena Wojdas; Krystyna Olczyk; Katarzyna Komosińska-Vassev
Journal:  J Clin Med       Date:  2022-04-04       Impact factor: 4.241

Review 4.  B Cells on the Stage of Inflammation in Juvenile Idiopathic Arthritis: Leading or Supporting Actors in Disease Pathogenesis?

Authors:  Rita A Moura; João Eurico Fonseca
Journal:  Front Med (Lausanne)       Date:  2022-04-04

5.  GAAGs, COMP, and YKL-40 as Potential Markers of Cartilage Turnover in Blood of Children with Juvenile Idiopathic Arthritis Treated with Etanercept-Relationship with ADAMTS4, ADAMTS5, and PDGF-BB.

Authors:  Klaudia Dąbkowska; Magdalena Wojdas; Kornelia Kuźnik-Trocha; Grzegorz Wisowski; Anna Gruenpeter; Katarzyna Komosińska-Vassev; Krystyna Olczyk; Katarzyna Winsz-Szczotka
Journal:  J Clin Med       Date:  2022-08-29       Impact factor: 4.964

6.  Human regulatory T cells locally differentiate and are functionally heterogeneous within the inflamed arthritic joint.

Authors:  Lisanne Lutter; M Marlot van der Wal; Eelco C Brand; Patrick Maschmeyer; Sebastiaan Vastert; Mir-Farzin Mashreghi; Jorg van Loosdregt; Femke van Wijk
Journal:  Clin Transl Immunology       Date:  2022-09-30
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.